• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AOA-2衍生物作为外膜蛋白A抑制剂用于治疗革兰氏阴性杆菌感染。

AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections.

作者信息

Ayerbe-Algaba Rafael, Bayó Nuria, Verdú Ester, Parra-Millán Raquel, Seco Jesús, Teixidó Meritxell, Pachón Jerónimo, Giralt Ernest, Smani Younes

机构信息

Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Rocío, Seville, Spain.

Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/Spanish National Research Council (CSIC)/University of Seville, Seville, Spain.

出版信息

Front Microbiol. 2021 Feb 12;12:634323. doi: 10.3389/fmicb.2021.634323. eCollection 2021.

DOI:10.3389/fmicb.2021.634323
PMID:33643267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7907166/
Abstract

Previously, we identified that a cyclic hexapeptide AOA-2 inhibited the interaction of Gram-negative bacilli (GNB) like , , and to host cells thereby preventing the development of infection and in a murine sepsis peritoneal model. In this work, we aimed to evaluate a library of AOA-2 derivatives in order to improve the effect of AOA-2 against GNB infections. Ten AOA-2 derivatives were synthetized for the assays. Their toxicities to human lung epithelial cells (A549 cells) for 24 h were evaluated by determining the A549 cells viability using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The effect of these peptide derivatives and AOA-2 at 250, 125, 62.5, and 31.25 μg/mL on the attachment of ATCC 17978, PAO1 and ATCC 25922 strains to A549 cells was characterized by adherence and viability assays. None of the 10 derivatives showed toxicity to A549 cells. RW01 and RW06 have reduced more the adherence of ATCC 17978, PAO1 and ATCC 2599 strains to A549 cells when compared with the original compound AOA-2. Moreover, both peptides have increased slightly the viability of infected A549 cells by PAO1 and ATCC 25922 than those observed with AOA-2. Finally, RW01 and RW06 have potentiated the activity of colistin against ATCC 17978 strain in the same level with AOA-2. The optimization program of AOA-2 has generated two derivatives (RW01 and RW06) with best effect against interaction of GNB with host cells, specifically against and .

摘要

此前,我们发现一种环状六肽AOA - 2可抑制诸如大肠杆菌、铜绿假单胞菌和肺炎克雷伯菌等革兰氏阴性杆菌(GNB)与宿主细胞的相互作用,从而在小鼠脓毒症腹膜模型中预防感染的发展。在这项研究中,我们旨在评估AOA - 2衍生物文库,以提高AOA - 2对GNB感染的疗效。合成了10种AOA - 2衍生物用于实验。通过使用3 -(4,5 - 二甲基噻唑 - 2 - 基)- 2,5 - 二苯基四氮唑溴盐法测定A549细胞活力,评估它们对人肺上皮细胞(A549细胞)24小时的毒性。通过黏附及活力测定,表征了这些肽衍生物和AOA - 2在250、125、62.5和31.25μg/mL浓度下对大肠杆菌ATCC 17978、铜绿假单胞菌PAO1和肺炎克雷伯菌ATCC 25922菌株黏附到A549细胞上的影响。这10种衍生物均未显示对A549细胞有毒性。与原始化合物AOA - 2相比,RW01和RW06更多地降低了大肠杆菌ATCC 17978、铜绿假单胞菌PAO1和肺炎克雷伯菌ATCC 2599菌株对A549细胞的黏附。此外,与AOA - 2相比,这两种肽均使被铜绿假单胞菌PAO1和肺炎克雷伯菌ATCC 25922感染的A549细胞的活力略有增加。最后,RW01和RW06增强了黏菌素对大肠杆菌ATCC 17978菌株的活性,与AOA - 2处于同一水平。AOA - 2的优化程序产生了两种对GNB与宿主细胞相互作用,特别是对大肠杆菌和铜绿假单胞菌具有最佳效果的衍生物(RW01和RW06)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f371/7907166/1e89788666a6/fmicb-12-634323-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f371/7907166/07fb154a8cc5/fmicb-12-634323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f371/7907166/036d3f7bec04/fmicb-12-634323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f371/7907166/1e89788666a6/fmicb-12-634323-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f371/7907166/07fb154a8cc5/fmicb-12-634323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f371/7907166/036d3f7bec04/fmicb-12-634323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f371/7907166/1e89788666a6/fmicb-12-634323-g003.jpg

相似文献

1
AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections.AOA-2衍生物作为外膜蛋白A抑制剂用于治疗革兰氏阴性杆菌感染。
Front Microbiol. 2021 Feb 12;12:634323. doi: 10.3389/fmicb.2021.634323. eCollection 2021.
2
Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.OmpA 抑制剂与多黏菌素联合应用对多黏菌素耐药鲍曼不动杆菌的协同作用:机制分析与体内疗效。
J Antimicrob Chemother. 2018 Dec 1;73(12):3405-3412. doi: 10.1093/jac/dky343.
3
Combating virulence of Gram-negative bacilli by OmpA inhibition.通过抑制 OmpA 来对抗革兰氏阴性菌的毒力。
Sci Rep. 2017 Oct 31;7(1):14683. doi: 10.1038/s41598-017-14972-y.
4
The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.奥克氯挫钠这种驱虫药可恢复多黏菌素对耐多黏菌素革兰氏阴性菌的活性。
Int J Antimicrob Agents. 2019 Oct;54(4):507-512. doi: 10.1016/j.ijantimicag.2019.07.006. Epub 2019 Jul 9.
5
Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli.新多黏菌素 B 类似物在革兰氏阴性菌中外膜相互作用动力学。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00935-19. Print 2019 Oct.
6
Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.针对生物膜中耐药革兰氏阴性菌的抗菌萘醌衍生物。
Microb Pathog. 2018 May;118:105-114. doi: 10.1016/j.micpath.2018.03.024. Epub 2018 Mar 14.
7
[Surveillance of resistance in the intensive care units using a cumulative antibiogram].[使用累积抗菌谱监测重症监护病房的耐药情况]
Mikrobiyol Bul. 2018 Oct;52(4):329-339. doi: 10.5578/mb.67408.
8
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
9
Prevalence and antibiotic resistance profiles of Gram negative bacilli associated with urinary tract infections (UTIs) in Karachi, Pakistan.巴基斯坦卡拉奇与尿路感染(UTIs)相关的革兰氏阴性杆菌的患病率及抗生素耐药谱
Pak J Pharm Sci. 2019 Nov;32(6):2617-2623.
10
Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.从 ICU 先前的同住病员中获得耐多药革兰氏阴性杆菌的风险。
Clin Microbiol Infect. 2011 Aug;17(8):1201-8. doi: 10.1111/j.1469-0691.2010.03420.x. Epub 2010 Dec 13.

引用本文的文献

1
AbOmpA in Acinetobacter baumannii: exploring virulence mechanisms of outer membrane-integrated and outer membrane vesicle-associated AbOmpA and developing anti-infective agents targeting AbOmpA.鲍曼不动杆菌中的AbOmpA:探索外膜整合型和外膜囊泡相关型AbOmpA的毒力机制并开发靶向AbOmpA的抗感染药物。
J Biomed Sci. 2025 May 27;32(1):53. doi: 10.1186/s12929-025-01147-5.
2
Therapeutic Effects of Inhibitor of Expression against Carbapenem-Resistant Strains.表达抑制剂对碳青霉烯类耐药株的治疗效果。
Int J Mol Sci. 2021 Nov 12;22(22):12257. doi: 10.3390/ijms222212257.
3
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.

本文引用的文献

1
Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.OmpA 抑制剂与多黏菌素联合应用对多黏菌素耐药鲍曼不动杆菌的协同作用:机制分析与体内疗效。
J Antimicrob Chemother. 2018 Dec 1;73(12):3405-3412. doi: 10.1093/jac/dky343.
2
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.发现、研究和开发新抗生素:世界卫生组织抗微生物药物耐药性和结核病优先病原体清单。
Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.
3
他莫昔芬代谢物的再利用治疗耐甲氧西林金黄色葡萄球菌和万古霉素耐药粪肠球菌感染。
Microbiol Spectr. 2021 Oct 31;9(2):e0040321. doi: 10.1128/Spectrum.00403-21. Epub 2021 Oct 20.
4
Screening of anti- phytochemicals, based on the potential inhibitory effect on OmpA and OmpW functions.基于对OmpA和OmpW功能的潜在抑制作用筛选抗植物化学物质。
R Soc Open Sci. 2021 Aug 18;8(8):201652. doi: 10.1098/rsos.201652. eCollection 2021 Aug.
Combating virulence of Gram-negative bacilli by OmpA inhibition.
通过抑制 OmpA 来对抗革兰氏阴性菌的毒力。
Sci Rep. 2017 Oct 31;7(1):14683. doi: 10.1038/s41598-017-14972-y.
4
Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase.鲍曼不动杆菌外膜蛋白A的过量产生作为医院获得性肺炎、菌血症和死亡率增加的危险因素。
J Infect Dis. 2017 Mar 15;215(6):966-974. doi: 10.1093/infdis/jix010.
5
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.抗药性时代的新型抗生素:针对有害细菌的抗毒力策略。
Nat Rev Drug Discov. 2017 Jul;16(7):457-471. doi: 10.1038/nrd.2017.23. Epub 2017 Mar 24.
6
Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI.抗毒力异喹啉甘露糖苷:优化联芳基苷元以提高对FimH凝集素的结合亲和力及治疗慢性尿路感染的疗效
ChemMedChem. 2016 Feb 17;11(4):367-73. doi: 10.1002/cmdc.201600006. Epub 2016 Jan 26.
7
Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.鉴定破坏群体感应调节的急性和持续性致病性的抗毒力化合物。
PLoS Pathog. 2014 Aug 21;10(8):e1004321. doi: 10.1371/journal.ppat.1004321. eCollection 2014 Aug.
8
rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids.rDock:一款用于将配体与蛋白质及核酸进行对接的快速、通用且开源的程序。
PLoS Comput Biol. 2014 Apr 10;10(4):e1003571. doi: 10.1371/journal.pcbi.1003571. eCollection 2014 Apr.
9
High-resolution comparative modeling with RosettaCM.使用 RosettaCM 进行高分辨率比较建模。
Structure. 2013 Oct 8;21(10):1735-42. doi: 10.1016/j.str.2013.08.005. Epub 2013 Sep 12.
10
Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii.外膜蛋白 Omp33 与鲍曼不动杆菌适应性和毒力的关联。
J Infect Dis. 2013 Nov 15;208(10):1561-70. doi: 10.1093/infdis/jit386. Epub 2013 Aug 1.